Home > Press > Thailand partners Korea in research collaboration
 |
| L-R: Dr. Choe and Dr. Thaweesak (holding the signed MOU) |
Abstract:
The National Science and Technology Development Agency (NSTDA) recently
signed a collaborative Memorandum of Understanding with Korea Research
Institute of Bioscience and Biotechnology (KRIBB) during NSTDA Annual
Conference 2011 on March 25.
Thailand partners Korea in research collaboration
Pathumthani, Thailand | Posted on March 28th, 2011
The MOU provides KRIBB with an opportunity to explore research
collaborative initiatives with any of the 4 research agencies within NSTDA.
In the area of nanotechnology, discussion between KRIBB and National
Nanotechnology Center (NANOTEC) focused on target drug delivery for
anticancer applications.
As Thailand is seeking to increase the amount of money spent on R&D to 1%
of GDP by 2013, NSTDA is working diligently to support this national policy
and to become a S&T solution providers for major industries in Thailand"
said Dr. Thaweesak Koanantakool, President of NSTDA. "Working with
capable partners such as KRIBB to exchange research knowledge and skill is a
significant pathway towards accomplishing this goal".
"The MOU will provide scientists from NSTDA and KRIBB with opportunity for
more active cooperation" said Dr. Yong Kyung Choe, President of KRIBB. "I
am confident the mutual ties between our two countries will create the
synergic effect in the years to come".
The Korean delegates included 13 participants from 5 research institute
were in town to participate in the Thailand-Korea Joint Symposium on
Nanobiotechnology. The aim of the symposium is to exchange research
information and explore research collaboration opportunities.
One of the research collaboration discusses is in the area of nanoparticles for
drug delivery.
"The research work at KRIBB on controlled antibody immobilization is very
interesting to us" said Dr. Warayuth Sajonsang, a NANOTEC researcher. "The
current focus of our research work is anticancer drug delivery. We feel our
research focus in nanoparticles drug delivery compliment the work at KRIBB
and can produce successful results that would be beneficial to healthcare
sector".
"The MOU is a good initiative to start the collaborative process" said Dr. Sang
JeonChung, Principal Investigator of BioNano Technology Research Center,
KRIBB. "We can certainly devote our knowledge to help modify the existing
NANOTEC research in nanoparticle by antibody or other targeting signal
peptides".
Specific research topics were discussed and action plan were identified in
which both NANOTEC and Korean delegation will work to put into action.
####
For more information, please click here
Contacts:
Ramjitti Indaraprasirt
Manager
International Relations Section
NANOTEC
02-564-7100 ext: 6617
Copyright © NANOTEC
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Nanomedicine
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Events/Classes
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Research and industry frontrunners gather in Dublin at the EuroNanoForum, Europe’s largest nanotechnology conference June 18th, 2013
Discover the ‘Nanostructure Advantage’ at ECerS 2013, Booth 5: Innovnano presents nanostructured powders for high performance ceramics June 17th, 2013
SEMATECH to Address Critical Supply Chain Challenges and Present Latest Technology Advances at SEMICON West 2013 June 17th, 2013
Alliances/Partnerships/Distributorships
Imec presents 4K2K CMOS image sensor together with Panasonic: The co-developed imager sensor chip targets high speed, high resolution imaging applications such as next generation HDTV June 18th, 2013
European Technology Platform for Nanomedicine and Nanomed2020 European Consortium Launch the Nanomedicine Award June 17th, 2013
SEMATECH to Address Critical Supply Chain Challenges and Present Latest Technology Advances at SEMICON West 2013 June 17th, 2013
SEMATECH Names William R. Rozich Chairman of the Board June 13th, 2013
Research partnerships
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Imec presents 4K2K CMOS image sensor together with Panasonic: The co-developed imager sensor chip targets high speed, high resolution imaging applications such as next generation HDTV June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013